36MO Patient-reported Outcomes in Primary Advanced or Recurrent Endometrial Carcinoma Treated with Atezolizumab or Placebo in Combination with Carboplatin-Paclitaxel in the AtTEnd/ENGOT-EN7 Trial

Y.C. Lee, N. Colombo, K. Harano,E. Rulli, E. Hudson, K.B. Lee,M. Rabaglio,I. Braicu, E. Petru, Y-C. Ou,E. Biagioli, A. Redondo, K. Takehara, K. Allan,Y. Antill,M. Lapresa,E. Piovano, G. Tasca, C. Zamagni,M.P. Barretina Ginesta

ESMO Open（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined